LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1878 | 3228 | 0.5819 | 0.4129 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1009 | 3228 | 0.3126 | 0.0347 |
Hs 578T | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 929 | 3013 | 3228 | 0.9334 | 0.9065 |
Hs 578T | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 929 | 761 | 3228 | 0.2359 | -0.0730 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1348 | 3228 | 0.4177 | 0.1823 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 2707 | 3228 | 0.8388 | 0.7736 |
Hs 578T | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 929 | 807 | 3228 | 0.2501 | -0.0530 |
Hs 578T | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 929 | 942 | 3228 | 0.2920 | 0.0058 |
Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 929 | 734 | 3228 | 0.2275 | -0.0848 |
Hs 578T | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 929 | 2965 | 3228 | 0.9187 | 0.8859 |
Hs 578T | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 929 | 3000 | 3228 | 0.9294 | 0.9008 |
Hs 578T | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 929 | 3417 | 3228 | 1.0586 | 1.0823 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1964 | 3228 | 0.6084 | 0.4501 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1915 | 3228 | 0.5932 | 0.4288 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1290 | 3228 | 0.3998 | 0.1572 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1040 | 3228 | 0.3224 | 0.0485 |
Hs 578T | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1637 | 3228 | 0.5071 | 0.3079 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 929 | 3229 | 3228 | 1.0004 | 1.0006 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 2989 | 3228 | 0.9261 | 0.8962 |
Hs 578T | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1491 | 3228 | 0.4620 | 0.2445 |
Hs 578T | R406 | 3.33 | uM | LJP6 | 72 | hr | 929 | 2188 | 3228 | 0.6779 | 0.5477 |
Hs 578T | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1645 | 3228 | 0.5098 | 0.3117 |
Hs 578T | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3184 | 3228 | 0.9866 | 0.9811 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 929 | 1218 | 3228 | 0.3775 | 0.1259 |
Hs 578T | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 929 | 1315 | 3228 | 0.4075 | 0.1680 |